Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

lawsuitplaintiffliabilityappealtestimonyburden of proof
litigationliabilitytestimony

Related Cases

In re Shell Oil Co., 202 S.W.3d 286
View Case »
John Allan Co. v. Craig Allen Co. L.L.C., 540 F.3d 1133, 87 U.S.P.Q.2d 1843
View Case »
Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta v. Florida, Not Reported in Fed. Supp., 2019 WL 13235645
View Case »
Johnson and Johnson v. Colgate-Palmolive Co., 345 F.Supp. 1216, 175 U.S.P.Q. 287
View Case »
Bertolli USA, Inc. v. Filippo Bertolli Fine Foods, Ltd., 662 F.Supp. 203, 6 U.S.P.Q.2d 1043
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

C.B. Fleet Co., Inc. v. SmithKline Beecham Consumer Healthcare, L.P., 131 F.3d 430, 1997-2 Trade Cases P 71,998, 45 U.S.P.Q.2d 1119

Facts

C.B. Fleet Company, Inc. (Fleet), a manufacturer of feminine hygiene products, brought a lawsuit against SmithKline Beecham Consumer Healthcare, L.P. (SmithKline) under the Lanham Act, alleging false advertising. The dispute arose after SmithKline launched an advertising campaign claiming that its Massengill douche cleansed better than Fleet's Summer's Eve douche. Fleet challenged two specific claims made by SmithKline: the 'Now Designed for Better Cleansing' claim and the 'comparative superiority' claim. The district court found in favor of SmithKline, leading Fleet to appeal the decision.

The events leading to this litigation began in 1991 when SmithKline, concerned about a declining market for its principal douche product, hired a marketing consultant to devise ways to truly differentiate its product from competing brands and so improve its market position.

Issue

Did the district court err in finding that SmithKline's advertising claims were not literally false under the Lanham Act?

Did the district court err in finding that SmithKline's advertising claims were not literally false under the Lanham Act?

Rule

To establish a violation of the Lanham Act, a plaintiff must prove that the contested advertisement is either false on its face or, if literally true, likely to mislead consumers in the context of the advertisement. If an advertising claim is literally false, the court may enjoin its use without considering its impact on the buying public. The determination of whether an advertisement is literally false is a question of fact.

Analysis

The court analyzed the claims made by SmithKline, distinguishing between 'bald' claims and those that imply test validation. The court found that the 'comparative superiority' claim did not imply that it was based on clinical testing, thus requiring Fleet to prove that the claim was literally false. The district court credited the expert testimony provided by SmithKline, which supported the reliability of their tests, leading to the conclusion that Fleet did not meet its burden of proof.

District court did not clearly err in finding that competitor's advertising claim that its douche product 'cleanses better' than manufacturer's similar product was not literally false, for purpose of manufacturer's false advertising claim under Lanham Act; district court simply chose to credit testimony of competitor's experts over that of manufacturer's experts as to reliability of competitor's tests, and expert testimony for both sides was equally coherent, plausible, and not contradicted by extrinsic evidence.

Conclusion

The Court of Appeals affirmed the district court's judgment in favor of SmithKline, concluding that Fleet failed to prove that the advertising claims were literally false.

Who won?

SmithKline Beecham Consumer Healthcare, L.P. prevailed in this case as the court found that Fleet did not provide sufficient evidence to prove that SmithKline's advertising claims were false. The district court credited the expert testimony from SmithKline, which indicated that their claims were supported by reliable testing. As a result, the court concluded that Fleet's challenges to the claims did not meet the necessary burden of proof required under the Lanham Act.

SmithKline Beecham Consumer Healthcare, L.P. prevailed in this case as the court found that Fleet did not provide sufficient evidence to prove that SmithKline's advertising claims were false.

You must be